Cell and gene therapies are an evolving treatment option for many diseases. They offer a level of personalisation that is important for patients with rare diseases that have perhaps previously had no therapeutic options.

NICE expects to review 30 new cell and gene therapy products this year alone, making the timing of this event important for those working in the healthcare sector.

Notable speakers for this event are Joseph ‘Mike’ McCune, the head of HIV frontiers at the Bill and Melinda Gates Foundation, Hugues Malonne, the general-director pre-authorisation for the Belgian Federal Agency for Medicines & Health Products, and Jennifer Lee, therapy area market access leader EMEA at Janssen.

Myaware will be attending this event as a media partner on the 24th of April and will communicate any developments in healthcare policy or future therapeutics via this page.

For more information on how to register for this event, visit the web page here. 

Learn more about research myaware are funding, click here 

Click here to learn more about online events myaware are hosting.